Osteoarthritis is a common chronic and degenerative disease among adults. A group of experts estimated the disease’s burden spanning two decades and the projection of burden to 2050.
Despite being approved for use, consensus among the real-world data on the use of IL-23 inhibitors in psoriatic disease has been lacking; therefore, researchers recently examined the drug survival and...
Researchers examined the efficacy and safety of a humanized monoclonal antibody for the treatment of active psoriatic arthritis in some patient populations.
The researchers evaluated the impact of antirheumatic treatment in women who are pregnant with psoriatic arthritis and how such treatment affects pregnancy outcomes.
Researchers conducted a trial to investigate the use of cannabidiol (CBD) to help manage pain in patients with psoriatic arthritis and hand osteoarthritis.
Researchers compared if early initiation of disease modifying antirheumatic drugs for the treatment of psoriatic arthritis was superior to later initiation of therapy after diagnosis in a recent study...
Researchers examined the treatment patterns in patients with adult Still disease in clinical practice and assessed changes in oral glucocorticoid dose after tocilizumab administration.
